Find information on thousands of medical conditions and prescription drugs.

Hypercholesterolemia

Hypercholesterolemia (literally: high blood cholesterol) is the presence of high levels of cholesterol in the blood. It is not a disease but a metabolic derangement that can be secondary to many diseases and can contribute to many forms of disease, most notably cardiovascular disease. It is closely related to the terms "Hyperlipidemia" (elevated levels of lipids) and "Hyperlipoproteinemia" (elevated levels of lipoproteins). more...

Home
Diseases
A
B
C
D
E
F
G
H
Hairy cell leukemia
Hallermann Streiff syndrome
Hallux valgus
Hantavirosis
Hantavirus pulmonary...
HARD syndrome
Harlequin type ichthyosis
Harpaxophobia
Hartnup disease
Hashimoto's thyroiditis
Hearing impairment
Hearing loss
Heart block
Heavy metal poisoning
Heliophobia
HELLP syndrome
Helminthiasis
Hemangioendothelioma
Hemangioma
Hemangiopericytoma
Hemifacial microsomia
Hemiplegia
Hemoglobinopathy
Hemoglobinuria
Hemolytic-uremic syndrome
Hemophilia A
Hemophobia
Hemorrhagic fever
Hemothorax
Hepatic encephalopathy
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatoblastoma
Hepatocellular carcinoma
Hepatorenal syndrome
Hereditary amyloidosis
Hereditary angioedema
Hereditary ataxia
Hereditary ceroid...
Hereditary coproporphyria
Hereditary elliptocytosis
Hereditary fructose...
Hereditary hemochromatosis
Hereditary hemorrhagic...
Hereditary...
Hereditary spastic...
Hereditary spherocytosis
Hermansky-Pudlak syndrome
Hermaphroditism
Herpangina
Herpes zoster
Herpes zoster oticus
Herpetophobia
Heterophobia
Hiccups
Hidradenitis suppurativa
HIDS
Hip dysplasia
Hirschsprung's disease
Histoplasmosis
Hodgkin lymphoma
Hodgkin's disease
Hodophobia
Holocarboxylase...
Holoprosencephaly
Homocystinuria
Horner's syndrome
Horseshoe kidney
Howell-Evans syndrome
Human parvovirus B19...
Hunter syndrome
Huntington's disease
Hurler syndrome
Hutchinson Gilford...
Hutchinson-Gilford syndrome
Hydatidiform mole
Hydatidosis
Hydranencephaly
Hydrocephalus
Hydronephrosis
Hydrophobia
Hydrops fetalis
Hymenolepiasis
Hyperaldosteronism
Hyperammonemia
Hyperandrogenism
Hyperbilirubinemia
Hypercalcemia
Hypercholesterolemia
Hyperchylomicronemia
Hypereosinophilic syndrome
Hyperhidrosis
Hyperimmunoglobinemia D...
Hyperkalemia
Hyperkalemic periodic...
Hyperlipoproteinemia
Hyperlipoproteinemia type I
Hyperlipoproteinemia type II
Hyperlipoproteinemia type...
Hyperlipoproteinemia type IV
Hyperlipoproteinemia type V
Hyperlysinemia
Hyperparathyroidism
Hyperprolactinemia
Hyperreflexia
Hypertension
Hypertensive retinopathy
Hyperthermia
Hyperthyroidism
Hypertrophic cardiomyopathy
Hypoaldosteronism
Hypocalcemia
Hypochondrogenesis
Hypochondroplasia
Hypoglycemia
Hypogonadism
Hypokalemia
Hypokalemic periodic...
Hypoparathyroidism
Hypophosphatasia
Hypopituitarism
Hypoplastic left heart...
Hypoprothrombinemia
Hypothalamic dysfunction
Hypothermia
Hypothyroidism
Hypoxia
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Signs and symptoms

Elevated cholesterol does not lead to specific symptoms unless it has been longstanding. Some types of hypercholesterolaemia lead to specific physical findings: xanthoma (thickening of tendons due to accumulation of cholesterol), xanthelasma palpabrum (yellowish patches around the eyelids) and arcus senilis (white discoloration of the peripheral cornea).

Longstanding elevated hypercholesterolemia leads to accelerated atherosclerosis; this can express itself in a number of cardiovascular diseases:

  • Angina pectoris, leading to PTCA or CABG
  • Myocardial infarction
  • Transient ischemic attacks (TIAs)
  • Cerebrovascular accidents/Strokes
  • Peripheral artery disease (PAOD)

Diagnosis

When measuring cholesterol, it is important to measure its subfractions before drawing a conclusion on the cause of the problem. The subfractions are LDL, HDL and VLDL. In the past, LDL and VLDL levels were rarely measured directly due to cost concerns. VLDL levels are reflected in the levels of triglycerides (generally about 45% of triglycerides is composed of VLDL). LDL was usually estimated as a calculated value from the other fractions (total cholesterol minus HDL and VLDL); this method is called the Friedewald calculation; specifically: LDL ~= Total Cholesterol - HDL - (0.2 x Triglycerides).

Less expensive (and less accurate) laboratory methods and the Friedewald calculation have long been utilized because of the complexity, labor and expense of the electrophoretic methods developed in the 1970s to identify the different lipoprotein particles which transport cholesterol in the blood. As of 1980, the original methods, developed by research work in the mid-1970s cost about $5K, US 1980 dollars, per blood sample/person.

With time, more advanced laboratory analyses have been developed which do measure LDL and VLDL particle sizes and levels, and at far lower cost. These have partly been developed and become more popular as a result of the increasing clinical trial evidence that intentionally changing cholesterol transport patterns, including to certain abnormal values compared to most adults, often has a dramatic effect on reducing, even partially reversing, the atherosclerotic process. With ongoing research and advances in laboratory methods, the prices for more sophisticated analyses have markedly decreased, to less than $100, US 2004, by some labs, and with simultaneous increases in the accuracy of measurement for some of the methods.

Read more at Wikipedia.org


[List your site here Free!]


Plant sterol esters in children with familial hypercholesterolemia - Lipids
From Nutrition Research Newsletter, 9/1/02

Familial hypercholesterolemia (FH) is associated with an increased risk of premature atherosclerosis and coronary artery disease (CAD). Consensus panels recommend that prevention of CAD should be initiated in childhood. Statins are the newest class of lipid-lowering drugs. However, treatment with statins has not been evaluated for long-term safety in patients younger than 18 years of age. Therefore, a dietary approach is most important in the treatment of children with FH. The recommended diet is based on a restriction of total and saturated fat. Saturated fat should be replaced by unsaturated fat; thus, butter should be replaced by a spread rich in unsaturated fats. In addition to supplying favorable fatty acids, vegetable oil spread may be a good source of plant sterols or phytosterols, which have been shown to reduce serum cholesterol levels.

Since there are little to no studies on the effect of plant sterol esters (SEs) in spread on blood cholesterol concentrations, carotenoids, fat-soluble vitamins and physiologic variables in young children with FH, new research is needed. A recent study in the American Journal of Clinical Nutrition estimated the potency of a SE-enriched spread, to reduce plasma concentrations of LDL cholesterol in children with FH and investigated the influence of SE-enriched spread on carotenoids and fat-soluble vitamins in serum and other physiologic variables in these children.

Thirty-eight children with FH participated in this double-blind crossover study comprising two 8-week interventions. First, a run-in period of three weeks checked compliance and standardized the spread intake. At the start of the first intervention period, the subjects were randomly assigned to eat 20 g SE-enriched spread or control spread per day for eight weeks and were switched to the other spread in the second intervention period. A physical examination and a history of disease were undertaken on day 1. Blood samples were drawn for plasma lipids at baseline and on day 1 and 56 of each intervention period. Weights were also checked at these intervals. The subjects and their families received some dietary instruction and were encouraged to make additional changes and to follow the dietary advice during the entire study.

The children consumed 90.9% of the control spread and 91.7% of the SE spread, which corresponds to a daily intake of 18 and 18.2 g of the control and SE spreads, respectively. Plasma LDL-cholesterol concentrations decreased by 10.2% during the SE period compared with the control period. Total cholesterol and apolipoprotein B concentrations were reduced by 7.4% during the SE period. No changes were observed in HDL cholesterol, triacylglycerol, or apolipoprotein A-I. Serum concentration of lipid-adjusted retinol and a-tocopherol concentrations increased by 15.6% and 7.1%, respectively. Food diaries showed that the children consumed the recommended American Heart Association Step 1 diet during both intervention periods.

A daily intake of 1.6 g of sterol esters induces an additional reduction in LDL-cholesterol concentrations in children with FH consuming a recommended diet. Besides the beneficial effects mentioned above, a reduction of 8.1% in serum lycopene was observed. The authors state that this small decrease is of minor biological and clinical importance. When plant sterol supplements are introduced as part of a lipid-lowering diet in children with FH, an increased intake of fruit and vegetables is recommended to compensate for a possible decrease in serum lycopene. The results show that a SE-enriched spread may be an effective and safe tool in the treatment of serum cholesterol in children with FH.

Agot L Amundsen, Leiv Ose, Marit S Nenseter, and Fady Y Ntanios, Plant Sterol Ester-Enriched Spread Lowers Plasma Total and LDL Cholesterol in Children with Familial Hypercholesterolemia, Am J Clin Nutr 76: 338-344 (July), 2002) [Address reprint requests to AL Amundsen, Institute for Nutrition Research, University of Oslo, PO Box 1046, Blindern, N-0316 Oslo, Norway. E-mail: a.l.amundsen@basalmed.uio.no]

COPYRIGHT 2002 Frost & Sullivan
COPYRIGHT 2002 Gale Group

Return to Hypercholesterolemia
Home Contact Resources Exchange Links ebay